Real-world studies confirm that pairing LONSURF with bevacizumab increases efficacy in patients with metastatic colorectal cancer </b ...

According to data from NHANES, there was no statistically significant correlation between increased serum iron levels and colorectal cancer risk.

With high-sensitivity and strong negative predictive value, this artificial intelligence (AI)-powered tool enhances early colorectal cancer (CRC) detection and risk stratification in primary care.

Lunit’s SCOPE HER2 AI model demonstrated an 86.7% accuracy compared to pathologist assessments for HER2 immunohistochemistry (IHC).

A colorectal cancer (CRC) screening public health initiative launched in Harbin, China has attracted about 830,000 participants for registration. The project utilizes fecal DNA methylation testing ...

The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a ...

Discover the latest evidence on optimal stopping ages for colorectal cancer screening based on age, sex, comorbidity, and ...

Cost-effectiveness and optimal stopping ages for colorectal cancer screening after age 75 years appear to be associated with ...

Health Canada has granted market authorisation to Takeda Canada for FRUZAQLA capsules to treat adults with mCRC.

Colorectal cancer remains the third most common malignancy worldwide, with advanced stages presenting significant challenges for treatment. A recently published study highlights the potential of ...

An Oxford company which uses AI to develop cancer treatments has achieved further validation for its approach to tackling multiple tumours. Oxford Drug Design's colorectal cancer model study on mice ...

Despite the availability of several noninvasive tests for colorectal cancer, prioritizing blood-based tests may result in ...